A5DQ25 NADH-cytochrome b5 reductase 1 MolNFT, Molecular NFT on GenesisL1

NADH-cytochrome b5 reductase 1

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD

IPFS of NFT metadata:

bafybeiapity3mt66pw3c7c6igapfhsjorbvrzqz4kyfc4wmiysmvam37iy/metadata.json

IPFS of structure file:

bafybeigrwv27fgoyn2txcgh36bm7m5kyi5sq22xzhblyj5c6lesins7ds4/AF-A5DQ25-F1-model_v2.pdb

First NFT owner address (eip-55):

0xc0F878C3f3E2a1874e2A6daC80d429e553DdB0D5

First NFT owner address (bech32):

genesis1cru83slnu2scwn32dkkgp4pfu4famvx4x7nssv

Current NFT ID #259985 owner (web3):

0x025f3b1a898b05AD2731bE6Ab72687b5920c4A3F

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
259985
Accession (UniProt):
A5DQ25
Name::
NADH-cytochrome b5 reductase 1
Experimental Method:
Predicted structure
Sequence source:
Meyerozyma guilliermondii (strain ATCC 6260 / CBS 566 / DSM 6381 / JCM 1539 / NBRC 10279 / NRRL Y-324)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A5DQ25 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A5DQ25|NCB5R_PICGU NADH-cytochrome b5 reductase 1 OS=Meyerozyma guilliermondii (strain ATCC 6260 / CBS 566 / DSM 6381 / JCM 1539 / NBRC 10279 / NRRL Y-324) OX=294746 GN=CBR1 PE=3 SV=1 MSQNEPNPLVIFSTLAAIILAAVAVYVVKLNKKNGPVLKPDVFQKFPLIEKTRLSHNTCIYRFGLPKSTDRLGLPIGQHISIGATINGKEVVRSYTPISRDDELGYFDLLIKTYEQGNISRHVDSKSVGDHIEVRGPKGFFTYTPNMVEHLGMIAGGTGIAPMYQVLTAILTNPDDKTKISLVYANVTEEDILLRAELDLFAKEHPDRFKVHYVLNNAPENWNGSVGFVTPEIMEKHLPNKDQDGYLLLCGPPPMISAMKKNAVTLGYPKARPVSKLGDKVFVF

A5DQ25 AF NFT

MOLNFT AF v1

NFT data

MOLNFT A5DQ25 research and analysis (ICN3D with VR)

FASTA sequences

We use cookies on this site to enhance your user experience